Bryan Burt named chief of thoracic surgery at UCLA Health

Catuvab device removes malignant cells from intraoperative blood salvage procedures

Topline results from the REMOVE certification study showed that Lindis Blood Care’s medical device Catuvab was safe and effective, meeting all primary and secondary endpoints.

April 26, 2024

Vol.50 No.17

Obituary

Edward Copeland, surgeon and breast cancer expert, dies at 86

A renowned surgeon and international authority on breast cancer, American College of Surgeons Past-President Edward (Ted) M. Copeland III, died on March 31 at the age of 86.

April 12, 2024

Vol.50 No.15

By Bulletin editorial team, American College of Surgeons

In the Archives

Edward M. Copeland III: “My lifestyle was practicing surgery”

In 2013, the American College of Surgeons conducted an oral history interview with former ACS president Edward M. Copeland III.

April 12, 2024

Vol.50 No.15

Clinical Roundup

Radiation before mastectomy cuts time delays for reconstructive surgery in breast cancer patients

Researchers at MD Anderson Cancer Center showed that altering the sequence of breast cancer treatment to administer radiation before mastectomy allowed for concurrent breast reconstruction surgery, which reduced the number of operations required, minimized treatment delays, and improved patient satisfaction.

April 12, 2024

Vol.50 No.15

Clinical Roundup

UCLA: Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence

A novel treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amount of time a person with stage 2 or 3 HR-positive, HER2-negative early breast cancer lives without the cancer returning, according to a phase III trial co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators.

March 29, 2024

Vol.50 No.13

Clinical Roundup

UCLA: Attacking metastatic prostate cancer early with combination treatment improves outcomes

A team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combination of a short course of powerful and intense hormonal therapy with targeted radiation is safe and effective in treating people with prostate cancer that has come back and has spread to other parts of the body.

March 22, 2024

Vol.50 No.12

Bryan Burt named chief of thoracic surgery at UCLA Health

YOU MAY BE INTERESTED IN

Catuvab device removes malignant cells from intraoperative blood salvage procedures

Edward Copeland, surgeon and breast cancer expert, dies at 86

Edward M. Copeland III: “My lifestyle was practicing surgery”

Radiation before mastectomy cuts time delays for reconstructive surgery in breast cancer patients

UCLA: Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence

UCLA: Attacking metastatic prostate cancer early with combination treatment improves outcomes

Renew today!

Subscriber content

Login